Related Experiment Video
Updated: May 16, 2026

Determining Glucose Metabolism Kinetics Using 18F-FDG Micro-PET/CT
Published on: May 2, 2017
[Study on pharmacokinetics of ginkgolide B injection in Beagle dogs]
Xian-tao Zhang1, Hao-yan Jiao, Qi-liang Suo
1Guangdong Research Institute of Traditional Chinese Medicine, Guangzhou 510520, China. zxtcpu@yahoo.com.cn
Objective:
To study the pharmacokinetics of ginkgolide B injection in Beagle dogs.
Methods:
Determined the serum concentration of ginkgolide B by LC-MS and calculated its parameter of pharmacokinetics via DAS 2.0 software.
Results:
After intravenous drips of 0.62, 2.07 and 10.35 mg/kg ginkgolide B, parameters of pharmacokinetics of ginkgolide B were as follows: Tmax were 0.444, 1, 1 h; Cmax were 0.764, 3.024, 11.013 mg/L; AUC(0-1) were 1.007, 3.644, 16.646 mg x h/Lo.
Conclusion:
Ginkgolide B has two compartment model in Beagle dogs.
Related Concept Videos
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Bioavailability Study Design: Single Versus Multiple Dose Studies
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
